跳至主要内容
临床试验/NCT02230956
NCT02230956已完成2 期

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

Allergan0 个研究点目标入组 176 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Allergan
入组人数
176
主要终点
Change From Baseline in the 7-Day Average Daily Pain Score Using an 11-Point Scale

研究概览

简要总结

This study will evaluate the efficacy and safety of a single intra-articular injection of 2 doses of BOTOX® (onabotulinumtoxinA) compared with placebo as treatment for knee osteoarthritis symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Painful osteoarthritis
  • Able to discontinue anti-inflammatory drugs and analgesics
  • Must be ambulatory without assistive walking devices

排除标准

  • Chronic pain conditions other than knee osteoarthritis
  • Treatment with corticosteroids in the study knee within 12 weeks
  • Treatment with hyaluronic acid in the study knee within 24 weeks
  • Previous treatment with any botulinum toxin for any reason
  • Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral sclerosis

研究组 & 干预措施

OnabotulinumtoxinA 400 U

Experimental

OnabotulinumtoxinA 400 U injection into the intra-articular space of the study knee on Day 1.

干预措施: onabotulinumtoxinA (Biological)

OnabotulinumtoxinA 200 U

Experimental

OnabotulinumtoxinA 200 U injection into the intra-articular space of the study knee on Day 1.

干预措施: onabotulinumtoxinA (Biological)

Placebo

Placebo Comparator

Placebo (Normal Saline) injection into the intra-articular space of the study knee on Day 1.

干预措施: Normal Saline (Drug)

结局指标

主要结局

Change From Baseline in the 7-Day Average Daily Pain Score Using an 11-Point Scale

时间窗: Baseline, Week 8

Participants recorded the pain in their knee during the previous 24 hours in a daily diary where: 0=no pain to 10= worst pain possible. The daily pain scores over 7-days were averaged. A negative change from Baseline indicates improvement.

次要结局

  • Patient Global Impression of Change (GIC) Using a 7-Point Scale(Weeks 1, 4, 8, 12, 16, 20 and 24)
  • Change From Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC™) Pain Score Using an 11-Point Scale(Baseline, Weeks 1, 4, 8, 12, 16, 20 and 24)
  • Change From Baseline in the WOMAC™ Physical Function Score Using an 11-Point Scale(Baseline, Weeks 1, 4, 8, 12, 16, 20 and 24)
  • Change From Baseline in the 7-Day Average Daily Worst Pain Score Using an 11-Point Scale(Baseline, Week 24)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验